Albuquerque, New Mexico 2021-05-10 18:21:04 –
The Food and Drug Administration has declared that the Pfizer vaccine is safe and provides strong protection for teens, based on tests by more than 2,000 US volunteers aged 12 to 15 years. Given dummy shot. More interestingly, researchers found that children developed antibodies that fight higher levels of the virus than previous studies measured in young adults.
Young teens received the same vaccine dose as adults and had the same side effects. It mainly indicates arm pain, flu-like fever, chills and pain, especially the recovery of the immune system after the second dose.
Pfizer’s tests in adolescence “meeted our stringent standards,” said Dr. Peter Marks, FDA Vaccine Chief. “Approving vaccines for young people is an important step in continuing to mitigate the enormous public health burden caused by the COVID-19 pandemic.”
Pfizer and its German partner BioNTech recently requested similar approval in the European Union.
The latest news is welcomed by US families who are struggling to determine which activities are safe to resume when only the youngest family is unvaccinated.
Carrie Vittito, a substitute teacher and freelance writer in Louisville, Kentucky, who is as fully vaccinated as her husband and 17-year-old daughter, said, “Because my boys are not vaccinated. I can’t feel completely comfortable. “
The FDA’s decision means that her 13-year-old son may soon qualify, leaving only the 11-year-old son who is not vaccinated. The family hasn’t resumed going to church yet, and summer vacation will be an expedition so they don’t have to fly.
“Two-fifths of the family are unprotected and cannot be returned to normal,” says Vittitoe.
Pfizer isn’t the only one trying to lower the age limit for vaccines. Moderna recently stated that preliminary results from a study between the ages of 12 and 17 showed strong protection and no serious side effects. Another US company, Novavax, was vaccinated with the COVID-19 vaccine late in development and just started research at the age of 12-17.
The next step is to test whether the vaccine works for younger children. Both Pfizer and Moderna have begun studies in the United States in children aged 6 months to 11 years. These studies investigate whether babies, preschoolers, and elementary school children need different doses than teens and adults. Pfizer is hoping for the first results in the fall, according to Gruber.
Outside the United States, AstraZeneca is studying vaccines for ages 6-17 in the United Kingdom. In China, Sinovac recently announced that it has submitted preliminary data to Chinese regulators showing that the vaccine is safe for children up to the age of three.
Children are much less likely to get a serious illness with COVID-19 than adults, but they are still hit hard by the pandemic. They account for almost 14% of national coronavirus cases. At least 296 people have died of COVID-19 and more than 15,000 have been hospitalized in the United States alone, according to the American Academy of Pediatrics.
It does not count the victims of illness or death of the family, or the disruption of school, sports and other activities that are very important to the overall well-being of the children.
The AAP welcomed the FDA’s decision.
“Our youngest generation has been under heavy burden over the past year, and vaccines are a sign of hope that they can begin to experience all the activities that are crucial to their health and development,” said AAP President. Said Dr. Lisa Bio. Statement beer.
Experts say children must take shots if the country immunizes 70% to 85% of the population needed to reach what is called herd immunity.
Meanwhile, the Centers for Disease Control and Prevention states that unvaccinated people, including children, should continue to take precautionary measures, such as wearing masks indoors and keeping them away from other unvaccinated people outside the home. say.
The Associated Press’s Department of Health Sciences is supported by the Department of Science Education at the Howard Hughes Medical Institute. AP is solely responsible for all content.
Pfizer COVID-19 shot expanded to US children as young as 12 Source link Pfizer COVID-19 shot expanded to US children as young as 12